Bariatric surgery for non-alcoholic steatohepatitis in obese patients (Q24240455)

non-alcoholic steatohepatitis

Europe PubMed Central

title

Bariatric surgery for non-alcoholic steatohepatitis in obese patients (English)

0 references

0 references

0 references

0 references

0 references

1 reference

6

Misael Uribe

0 references

Norberto Carlos Chávez-Tapia

Tonatiuh Barrientos-Gutiérrez

1

object named as

Norberto C Chavez-Tapia

0 references

object named as

Tonatiuh Barrientos-Gutierrez

3

0 references

author name string

Felix I Tellez-Avila

2

0 references

Nahum Mendez-Sanchez

4

0 references

Javier Lizardi-Cervera

Cochrane Database of Systematic Reviews

5

0 references

publication date

20 January 2010

0 references

published in

0 references

cites work

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Hepatic outcomes after jejunoileal bypass: is there a publication bias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Liver and heart: a new link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Clinical hepatology: profile of an urban, hospital-based practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Hepatic steatosis: innocent bystander or guilty party?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Clinical features and natural history of nonalcoholic steatosis syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Adiponectin: A novel adipokine linking adipocytes and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

A call for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007340.PUB2

[Non-alcoholic steatohepatitis]

21 January 2018

1 reference

12 December 2020

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

1 reference

12 December 2020

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

12 December 2020

Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome

1 reference

12 December 2020

[Therapeuric aspects of NAFLD. A literature review]

1 reference

12 December 2020

Role of nonalcoholic fatty liver disease in hepatocellular carcinoma.

1 reference

12 December 2020

Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis

1 reference

12 December 2020

Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data.

1 reference

12 December 2020

Association among C-reactive protein, Fatty liver disease, and cardiovascular risk

1 reference

12 December 2020

Nonalcoholic fatty liver disease and its association with cardiovascular disease.

1 reference

12 December 2020

Regression of Hepatic Steatosis in Morbidly Obese Persons After Gastric Bypass

1 reference

12 December 2020

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease

1 reference

12 December 2020

The evolution of severe steatosis after bariatric surgery is related to insulin resistance

1 reference

12 December 2020

Resolution of nonalcoholic steatohepatits after gastric bypass surgery

1 reference

12 December 2020

Histological findings in the liver before and after gastric bypass

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies

1 reference

12 December 2020

Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years

1 reference

12 December 2020

Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity

1 reference

12 December 2020

The impact of age and Medicare status on bariatric surgical outcomes

1 reference

12 December 2020

Nonalcoholic fatty liver disease treated by gastroplasty

1 reference

12 December 2020

10.1002/14651858.CD007340.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20091629

1 reference

Consolidated OpenCitations Corpus – April 2017